The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy is a research paper published in Frontiers in Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 267 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Veterans Affairs
Grant: I01BX004903 , I01BX002922 , IK6 BX004855
National Cancer Institute
Grant: R01CA07059 , F30CA236031 , R01CA242003 , R01CA217907, R21CA255291
NCI NIH HHS
Grant: R21 CA255291
BLRD VA
Grant: I01 BX002922
BLRD VA
Grant: I01 BX004903
BLRD VA
Grant: IK6 BX004855
NCI NIH HHS
Grant: R01 CA217907
NCI NIH HHS
Grant: R01 CA242003
NCI NIH HHS
Grant: F30 CA236031
National Institutes of Health
Grant: 5I01BX002922-04
Targeting MNK Pathways in Pancreatic Cancer
National Institutes of Health
Grant: 1R21CA255291-01
Rapid evaluation of immunotherapy regimens in ex vivo human pancreatic tumor slice cultures.
National Institutes of Health
Grant: 5R01CA242003-03
Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancer
National Institutes of Health
Grant: 5F30CA236031-02
Augmenting Pancreatic Cancer Immunotherapy via TGFβ Pathway Inhibition
National Institutes of Health
Grant: 5I01BX004903-03
Rational Combination of MAP4K4 Inhibition and Immunotherapy in Pancreatic Cancer
National Institutes of Health
Grant: 5R01CA217907-02
Galpha13 and pancreatic cancer progression
FWCI
15.21
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals